- Rating
- 3(+1)
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 2
Read review
Paper summary
The paper presents PHISA for multimodal cancer survival prediction. It models relations among histology regions with a complex-valued polarized hypergraph and adapts BioMistral to patient-level transcriptomic information through tissue-conditioned spectral adaptation (TCSA). Results are reported on four TCGA cohorts using survival discrimination and calibration-related metrics, with component ablations and comparisons among adaptation strategies.
Critical strengths
The paper presents PHISA for multimodal cancer survival prediction. It models relations among histology regions with a complex-valued polarized hypergraph and adapts BioMistral to patient-level transcriptomic information through tissue-conditioned spectral adaptation (TCSA). Results are reported on four TCGA cohorts using survival discrimination and calibration-related metrics, with component ablations and comparisons among adaptation strategies
Critical weaknesses
- The biological interpretation of learned phases is not directly validated. Eq. (2) learns complex orientations from region and hyperedge features without supervision on cellular cooperation or antagonism. Theorem 2 establishes a mathematical response under the restrictive opposing-feature assumption, but does not show that learned phase differences correspond to actual tissue interactions. This leaves an important part of the proposed motivation empirically untested.
- The adaptation comparison does not fully isolate the proposed mechanism. Table 3 compares patient-structure-conditioned TCSA against task-level LoRA, PiSSA, and SVFT, changing both the conditioning information and the adaptation rule. Although Table 5 reports favorable paired fold-level tests, the large READ gain is obtained from 172 patients with 83.72% censoring (28 observed events). The five fold-level observations do not by themselves establish patient-level uncertainty or external reproducibility.
Questions for authors
- Is there independent quantitative evidence relating learned phase differences to annotated tissue-cell interactions or spatial-molecular patterns, beyond the idealized algebraic result?
- Does TCSA outperform a parameter-matched patient-conditioned LoRA or another conditional adapter? How much of the gain depends specifically on BioMistral?
- How robust are the READ findings under patient-level resampling, alternative survival splits, and independent-cohort evaluation, particularly given the limited number of observed events?
Follow up on our responses
Dear Reviewer PGB6,
Thank you again for your thoughtful review and constructive suggestions. We have carefully responded to your concerns by providing quantitative evidence relating learned phase differences to cellular spatial patterns (W1/Q1), comparing TCSA with Cond. Adapter under the same patient tissue descriptor and PEFT parameter budget (W2/Q2), examining BioMistral and Mistral under matched adaptation settings (W2/Q2), and evaluating READ robustness through patient resampling and alternative survival splits (W2/Q3).
We would sincerely appreciate it if you could review our responses when convenient and let us know whether these additional explanations and results have helped address your concerns. We would be happy to discuss any remaining questions or provide further clarification.
Thank you very much for your time and consideration.
Authors of Submission #27354